CAR-T Congress EU 2019
January 30, 2019 ‐ January 31, 2019 in London, UK
The CAR-T Congress EU 2019 will be held from January 30 to 31, 2019 in London, United Kingdom.
David Sourdive, Ph.D., Executive Vice President, Technical Operations, to take part in this event on January 30 with a presentation entitled "How gene editing is transforming adoptive T-cell therapies - lessons learnt in bringing allogeneic products to the clinic, and outlook to the next generation designer T-cell products" at 9:55 AM CET. Then he will participate in a panel that will discuss "Allogeneic vs autologous: 1) Safety considerations needed with donor-derived therapies, and the strategies needed to ensure high standards of quality control and screening and 2) Gaining a deeper understanding of the causes of toxicities, and mechanisms to avoid cytokine release syndrome, neurologic toxicity, “on target/off tumor” recognition, and anaphylaxis" at 4:00 PM CET.